Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
NeoSync, Inc. logo — Pioneering non-invasive neuromodulation solutions for Centra...

NeoSync, Inc.

Pioneering non-invasive neuromodulation solutions for Central Nervous System disorders, led by seasoned medical device innovators.

Founded 2008 United States Boston, United States 4 employees Series D Total: $13.00M Information Technology

General Information

Company Name NeoSync, Inc.
Founded Year 2008
Location United States Boston, United States +1
Founders / Decision Makers
Team member
Employees 4
Industries Information Technology
Funding Stage Series D
Social

Get notified when NeoSync, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NeoSync, Inc.

NeoSync is a clinical-stage company founded in 2008 that is pioneering non-invasive neuromodulation solutions for Central Nervous System disorders. Their proprietary platform technology is geared towards developing advanced, non-invasive neuromodulation products aimed at treating Major Depressive Disorder and other Central Nervous System diseases such as Autism, Parkinson's Disease, Anxiety, and Post Traumatic Stress Disorder. Led by a team of seasoned medical device executives and entrepreneurs, NeoSync aims to revolutionize the treatment of these conditions. The company recently secured a significant $13.00M Series D investment on 10 August 2017 from Valiance Advisors, highlighting the confidence that investors have in their innovative solutions. With its strong leadership and groundbreaking technology, NeoSync presents a compelling opportunity for venture capitalists seeking to support advancements in healthcare and technology.

Taxonomy: neuromodulation, Central Nervous System disorders, clinical-stage company, non-invasive treatment, Major Depressive Disorder, Autism, Parkinson's Disease, Anxiety, Post Traumatic Stress Disorder, proprietary platform technology, seasoned medical device innovators, entrepreneurship, startup, investors

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 1
Investor
10 Aug 2017

FAQ About NeoSync, Inc.

Pioneering non-invasive neuromodulation solutions for Central Nervous System disorders, led by seasoned medical device innovators.
NeoSync, Inc. was founded in 2008.
NeoSync, Inc. is headquartered in Boston, United States.
NeoSync, Inc. operates in the following industries: Information Technology.
NeoSync, Inc. has approximately 4 employees.
NeoSync, Inc. has completed 1 funding round, raising a total of $13.00M. The latest funding stage is Series D.

We're actively collecting intelligence on NeoSync, Inc..

Track NeoSync, Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors NeoSync, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy